ResMed (RMD) July out of the money puts active as share price down 12%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Oppenheimer Downgrades ResMed (RMD) to Perform
June 25, 2024 6:02 AM EDTOppenheimer analyst Suraj Kalia downgraded ResMed (NYSE: RMD) from Outperform to Perform.
The analyst comments "SURMOUNT-OSA dataset was presented at ADA (NEJM link) on 06/21. While we have discussed GLP-1s/SURMOUNT-OSA at length and the risk we believe they represent to the... More
